glp-1 conference food beverage retail fitness speaking opportunities Caution advised for labeling Hidden hunger: As food 'noise'
Description
Serious but Less Common Side Effects: Pancreatitis: Rare, but a known risk
Faour, M., Magnan, C., Gurden, H
Food & Drug Administration (2021) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes, U.S
Other oral are in FDA review and could hit the market in 2024
Other contributors may include medications associated with weight gain and endocrine conditions such as hypothyroidism
